Low-dose PD-1 inhibitor combined with lenvatinib for preemptive treatment of recurrence after liver transplantation for hepatocellular carcinoma: Case report and literature review

Orthotopic liver transplantation (OLT), as one of the curative methods for the treatment of hepatocellular carcinoma (HCC), has brought hope to patients with HCC. However, treatment options for HCC recurrence and metastasis after liver transplantation are limited. Immune checkpoint inhibitor (ICI),...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Xin, Zhang, Kangjun, Fang, Taishi, Zeng, Xinchen, Yan, Xu, Tang, Jianxin, Liang, Ziming, Xie, Linjie, Zhao, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478730/
https://www.ncbi.nlm.nih.gov/pubmed/36119543
http://dx.doi.org/10.3389/fonc.2022.951303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478730/
https://www.ncbi.nlm.nih.gov/pubmed/36119543
http://dx.doi.org/10.3389/fonc.2022.951303

Ejemplares similares